LIVER

Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy

C Skipper¹, J M Guy², J Parkes³, P Roderick³, W M Rosenberg⁴

¹ HMP Parkhurst, Isle of Wight, UK
² Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, Southampton, UK
³ Health Services Research Unit, Liver Epidemiology Group, Division of Community Clinical Sciences, University of Southampton, Southampton, UK
⁴ Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, and Health Services Research Unit, Liver Epidemiology Group, Division of Community Clinical Sciences, University of Southampton, Southampton, UK

Correspondence to:
Correspondence to:
Dr W M C Rosenberg, Liver Group, Division of Infection, Inflammation, and Repair, Mailpoint 811, Level D South Block, Southampton General Hospital, Tremona Rd, Southampton, Hampshire SO16 6YD, UK;
wmr{at}soton.ac.uk

Background: Hepatitis C virus (HCV) infection is a major public health problem recognised by the UK National Strategy that proposes that a care pathway for assessment, diagnosis, and treatment be established in all prisons, integrated within managed clinical networks. A prison sentence provides the opportunity to focus on traditionally hard to reach patients.

Aims: To evaluate the prevalence of HCV infection in a UK prison cluster and to assess the effectiveness of a prison outreach service for hepatitis C.

Subjects: Male prisoners.

Methods: A nurse specialist led clinic within a cluster of adult prisons was established, offering health education on hepatitis C, advice on harm minimisation, and HCV testing. Infected prisoners were offered access to a care pathway leading to treatment. Outcome measures were uptake of the service, and diagnosis and treatment of hepatitis C.

Results: A total of 8.5% of 1618 prisoners accepted testing: 30% had active infection with HCV. Most were ineligible for treatment due to psychiatric illness or did not receive treatment for logistic reasons. Injecting drug use was the major risk factor in all cases. Only 7% of HCV polymerase chain amplification positive inmates received treatment in prison.

Conclusion: There is a large pool of HCV infected prisoners at risk of complications, constituting a source of infection during their sentence and after discharge. A prison outreach clinic and care pathway was perceived as effective in delivering health education, reducing the burden on prison and hospital services. It provided an opportunity for intervention but had a limited effect in eradicating HCV in prisoners and it remains unclear how this might be achieved.

Keywords: hepatitis C virus; prison; prevalence; outreach clinic

Abbreviations: HCV, hepatitis C virus; IDU, injecting drug users; HWC, healthwatch clinic; POC, prison outreach clinic; HIV, human immunodeficiency virus; PCR, polymerase chain reaction amplification

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller
Gut 2003 52: 1391. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Condon, L., Hek, G., Harris, F. (2008). Choosing health in prison: Prisoners' views on making healthy choices in English prisons. Health Education Journal 67: 155-166 [Abstract]  
• Magee, C. G., Hult, J. R., Turalba, R., McMillan, S. (2005). Preventive Care for Women in Prison: A Qualitative Community Health Assessment of the Papanicolaou Test and Follow-Up Treatment at a California State Women's Prison. AJPH 95: 1712-1717 [Abstract] [Full Text]  

eLetters:

Read all eLetters

In search of the correct strategy for preventing the spread of HCV infection...

Maurizio Montella, et al.

Gut Online, 6 Nov 2003 [Full text]